Bendokey 100 mg Powder for concentrate for solution for infusion

Bendokey 100 mg Powder for concentrate for solution for infusion is a powerful chemotherapy medication used in the treatment of various types of cancer. This medication contains Bendamustine Hydrochloride, an alkylating agent that works by damaging the DNA of cancer cells, thereby inhibiting their growth and division. It is commonly prescribed for conditions such as Chronic Lymphocytic Leukemia (CLL), non-Hodgkin lymphoma (NHL), and multiple myeloma.

As referenced on leading pharmaceutical information portals like Nahdionline, , and , Bendokey is administered under strict medical supervision in a clinical setting to ensure optimal efficacy and patient safety.

Benefits of Use

• Targets and inhibits the proliferation of cancer cells.
• Effective in treating specific types of lymphomas and leukemias.
• Contributes to disease remission and improved patient outcomes when used as part of a comprehensive treatment plan.

How to Use

1. Bendokey is for intravenous administration only.
2. It must be prepared and administered by a qualified healthcare professional experienced in the use of chemotherapeutic agents.
3. The powder is reconstituted with sterile water for injection and then further diluted with an appropriate infusion solution (e.g., sodium chloride 0.9% or glucose 5%).
4. The dose and duration of treatment cycles are determined by the treating physician based on the patient's condition, weight, body surface area, and response to therapy.
5. Administer the diluted solution as an intravenous infusion over 30 to 60 minutes, typically on specific days of a treatment cycle.

Caution & Warnings

• Strictly for use under the guidance of an oncologist.
• May cause severe bone marrow suppression, leading to reduced blood cell counts. Regular blood tests are crucial.
• Risk of infections: Patients should be monitored for signs of infection and seek immediate medical attention if symptoms occur.
• Potential for severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
• Can cause infusion-related reactions (fever, chills, rash, hypotension).
• Teratogenic: Avoid use during pregnancy. Women of childbearing potential should use effective contraception.
• Not recommended for breastfeeding mothers.
• Avoid in patients with severe liver or kidney impairment without dose adjustment.
• Handle with care: As a cytotoxic drug, proper handling and disposal procedures must be followed.

Ingredients

• Active Ingredient: Bendamustine Hydrochloride 100 mg
• Excipients: Please refer to the product's official package leaflet for a comprehensive list of excipients.

Product Details

• Form: Powder for concentrate for solution for infusion
• Strength: 100 mg
• Package Type: Vial
• Manufacturer: Dr. Reddy's Laboratories